MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517074236 A) filed by Virion Therapeutics, Llc; and The Wistar Institute, Newark, U.S.A., on Aug. 4, for 'glycoprotein d variants as vaccine adjuvants.'
Inventor(s) include Ertl, Hildegund CJ; Currie, Sue L; and Luber, Andrew D.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "Disclosed herein are compositions for increasing the immunogenicity of a vaccine antigen and methods of inducing an immune response in a subject using the compositions described herein. Disclosed herein are compositions for a therapeutic vaccine to HPV- associated cancers and methods of inducing an immune response to HPV in a subject using the compositions described herein."
The patent application was internationally filed on Jan. 09, 2024, under International application No.PCT/US2024/010802.
Disclaimer: Curated by HT Syndication.
